INFORMED.
LIVE

Dishman Carbogen Amcis Limited

BSE: DCAL540701ISIN INE385W01011
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹170.45+8.40 (+5.18%)
as of 18 Sep 2026
Dishman Carbogen Amcis Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹286.00 to ₹170.45 (-40.4%). Low ₹143.00, high ₹314.10. Volume shown below the price.
52W high
₹321.15
52W low
₹129.00
Off 52W high
-46.93%
1M return
-1.04%
3M return
-0.20%
6M return
+7.44%
1Y return
-40.40%
20D avg volume
18,223
50 DMA
₹181.59
200 DMA
₹193.20

Key ratios Consolidated

Market cap
₹2,672 Cr
Current price
₹170.45
52W high / low
₹321.15 / ₹129.00
Face value
₹2.00
P/E
165.37
P/B
EPS (TTM)
₹1.03
Book value / share
ROE
ROCE
2.90%
Operating margin
Net margin
Debt / equity
0.42
Net debt
₹1,988 Cr
Interest cover
1.60
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
184.4 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
677.64851.40719.80652.65708.05716.34
18.1616.426.668.1124.757.97
745.33820.54736.90630.22691.48684.86
144.66120.36127.7934.10205.60154.15
0.000.000.000.000.000.00
389.10406.21355.88332.94351.90324.94
37.0943.3045.7942.3342.7642.12
90.6888.7984.4284.1381.3579.09
114.23147.33109.33136.51117.3892.80
-49.5347.28-10.4430.5441.3239.45
-1.69-1.150.000.00-2.65-11.75
-51.2246.13-10.4430.5438.6727.70
6.6624.392.53-34.7315.26-15.39
-57.8821.74-12.9765.2723.4143.09
-3.691.39-0.834.161.492.75
Key metrics
76.55178.22119.77157.00162.78148.91
11.30%20.90%16.60%24.10%23.00%20.80%
-8.50%2.60%-1.80%10.00%3.30%6.00%
0.90%0.80%0.90%
-4.30%18.90%
-347.20%-49.50%
MetricTTMFY26FY25FY24
Income statement
2,9012,9322,712
49.3555.9421.68
2,9332,8792,696
426.91487.85592.96
0.000.000.00
1,4841,4471,294
168.51174.18159.46
348.02338.69293.74
507.40510.55447.34
17.85108.7037.42
-2.84-3.80-18.11
15.01104.9019.31
-1.157.4516.07
16.1697.453.24
1.036.220.21
Key metrics
531.54617.77472.51
18.32%21.10%17.40%
0.56%3.30%0.10%
2.90%2.20%
8.10%
2,907.70%
225.47158.47
5.04115.81
0.420.36
1,9881,743
184.4179.6
Balance sheet
11,9239,999
2,8422,200
787.76341.07
672.91665.14
1,019900.24
116.0283.62
2,9422,684
211.18230.68
2,3171,925
2,7752,084
1,241934.72
1,5351,149
6,6775,832
Cash flow
491.45375.23
-245.34-192.21
200.58-102.09
265.98216.76
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
57.0868.7239.6860.3062.86106.10
18.8928.837.1011.1737.425.47
105.98105.0381.8592.2996.16122.98
15.3913.3517.9211.1913.2122.75
0.000.000.000.000.000.00
21.0521.1821.4321.7422.2821.09
21.7122.1423.5120.6120.2621.31
15.3715.1515.1615.7916.4716.10
34.1529.6822.9422.0025.6831.99
-30.01-7.48-35.07-20.824.12-11.41
-1.690.000.000.000.000.00
-31.70-7.48-35.07-20.824.12-11.41
-7.79-3.14-11.94-7.221.45-4.04
-23.91-4.34-23.13-13.602.67-7.37
-1.52-0.28-1.47-0.870.17-0.47
Key metrics
5.3829.813.6015.5840.8526.00
9.40%43.40%9.10%25.80%65.00%24.50%
-41.90%-6.30%-58.30%-22.60%4.20%-6.90%
0.30%0.00%0.20%
-9.20%-35.20%
-995.50%41.10%
MetricTTMFY26FY25FY24
Income statement
225.78231.56399.84
65.9984.5232.98
385.15375.33463.65
57.8555.67117.01
0.000.000.00
85.4086.6390.15
87.9786.5270.40
61.4762.5765.20
108.77100.30106.89
-93.38-59.25-30.83
-1.690.000.00
-95.07-59.25-30.83
-30.09-20.85-20.96
-64.98-38.40-9.87
-4.14-2.45-0.63
Key metrics
54.3789.84104.77
24.08%38.80%26.20%
-28.78%-16.60%-2.50%
0.60%0.90%
-42.10%
-289.10%
19.120.91
-1.20-5.65
0.160.17
614.69610.83
394.7216.4
Balance sheet
5,1265,122
689.70674.98
15.9367.73
170.62174.75
155.12134.25
26.3119.79
781.98798.17
75.2971.99
868.90652.10
630.62678.56
506.76430.87
123.86247.69
3,8824,030
Cash flow
46.1155.81
21.68-79.64
-119.5987.51
26.9954.90

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
59.32%
HolderTypeHoldingPreviousChange
Adimans Technologies LLPPromoter59.32%
Mukul Mahavir AgrawalPublic5.50%
Massachusetts Institute Of TechnologyPublic2.28%
Hbm Healthcare Investments (Cayman) LtdPublic2.19%
Hsbc Mutual Fund - Hsbc Flexi Cap FundPublic1.41%
Ms. Aamanya Arpit VyasPromoter Group0.00%
Zenon Therapeutics AGPromoter Group0.00%
Ms. Anika Arpit VyasPromoter Group0.00%
Janmejay Vyas Family Trust (Janmejay R. Vyas - Trustee)Promoter Group0.00%
RTV Technochem Private LimitedPromoter Group0.00%
Arpit Vyas Family Trust (Arpit J. Vyas - Trustee)Promoter Group0.00%
Aditi Vyas Family Trust (Aditi J. Vyas - Trustee)Promoter Group0.00%
Janmejay Rajnikant Vyas - HUF (Late Janmejay R. Vyas - Karta)Promoter Group0.00%
JRV Techpark Pvt LtdPromoter Group0.00%
Vyas Family Trust (Janmejay R. Vyas and Deohooti J. Vyas - Managing Trustees)Promoter Group0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results